http://purl.org/np/RAbSm0mV_DjuDcEx-sPIiVILXrrkkY385kOyaa7pxYF0A#Head
http://purl.org/np/RAbSm0mV_DjuDcEx-sPIiVILXrrkkY385kOyaa7pxYF0A
http://www.nanopub.org/nschema#hasAssertion
http://purl.org/np/RAbSm0mV_DjuDcEx-sPIiVILXrrkkY385kOyaa7pxYF0A#assertion
http://purl.org/np/RAbSm0mV_DjuDcEx-sPIiVILXrrkkY385kOyaa7pxYF0A
http://www.nanopub.org/nschema#hasProvenance
http://purl.org/np/RAbSm0mV_DjuDcEx-sPIiVILXrrkkY385kOyaa7pxYF0A#provenance
http://purl.org/np/RAbSm0mV_DjuDcEx-sPIiVILXrrkkY385kOyaa7pxYF0A
http://www.nanopub.org/nschema#hasPublicationInfo
http://purl.org/np/RAbSm0mV_DjuDcEx-sPIiVILXrrkkY385kOyaa7pxYF0A#pubinfo
http://purl.org/np/RAbSm0mV_DjuDcEx-sPIiVILXrrkkY385kOyaa7pxYF0A
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.nanopub.org/nschema#Nanopublication
http://purl.org/np/RAbSm0mV_DjuDcEx-sPIiVILXrrkkY385kOyaa7pxYF0A#assertion
http://purl.obolibrary.org/obo/DOID_409
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Disease
http://purl.org/np/RAbSm0mV_DjuDcEx-sPIiVILXrrkkY385kOyaa7pxYF0A#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#object
http://purl.obolibrary.org/obo/DOID_409
http://purl.org/np/RAbSm0mV_DjuDcEx-sPIiVILXrrkkY385kOyaa7pxYF0A#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate
https://w3id.org/biolink/vocab/treats
http://purl.org/np/RAbSm0mV_DjuDcEx-sPIiVILXrrkkY385kOyaa7pxYF0A#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
https://identifiers.org/drugbank:DB01039
http://purl.org/np/RAbSm0mV_DjuDcEx-sPIiVILXrrkkY385kOyaa7pxYF0A#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement
http://purl.org/np/RAbSm0mV_DjuDcEx-sPIiVILXrrkkY385kOyaa7pxYF0A#association
http://www.w3.org/2000/01/rdf-schema#label
"Fenoglide is contraindicated in patients with severe renal dysfunction, including those receiving dialysis [see Clinical Pharmacology (12.3) Fenoglide is contraindicated in patients with active liver disease, including those with primary biliary cirrhosis and unexplained persistent liver function abnormalities [see Warnings and Precautions (5.1) Fenoglide is contraindicated in patients with gallbladder disease [see Warnings and Precautions (5.2) Fenoglide is contraindicated in nursing mothers [see Use in Specific Populations (8.3) Fenoglide is contraindicated in patients who have a known hypersensitivity to fenofibrate, such as severe skin rashes, including Stevens-Johnson syndrome and toxic epidermal necrolysis. [see Warnings and Precautions (5.9) Severe renal dysfunction, including patients receiving dialysis ( 4 12.3 Active liver disease ( 4 5.1 Gallbladder disease ( 4 5.2 Nursing mothers ( 4 8.3"
http://purl.org/np/RAbSm0mV_DjuDcEx-sPIiVILXrrkkY385kOyaa7pxYF0A#association
https://w3id.org/biolink/vocab/provided_by
https://w3id.org/um/NeuroDKG
http://purl.org/np/RAbSm0mV_DjuDcEx-sPIiVILXrrkkY385kOyaa7pxYF0A#association
https://w3id.org/biolink/vocab/relation
https://schema.org/MedicalContraindication
https://identifiers.org/drugbank:DB01039
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Drug
http://purl.org/np/RAbSm0mV_DjuDcEx-sPIiVILXrrkkY385kOyaa7pxYF0A#provenance
http://purl.org/np/RAbSm0mV_DjuDcEx-sPIiVILXrrkkY385kOyaa7pxYF0A#assertion
http://www.w3.org/ns/prov#wasAttributedTo
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RAbSm0mV_DjuDcEx-sPIiVILXrrkkY385kOyaa7pxYF0A#pubinfo
http://purl.org/np/RAbSm0mV_DjuDcEx-sPIiVILXrrkkY385kOyaa7pxYF0A#sig
http://purl.org/nanopub/x/hasAlgorithm
RSA
http://purl.org/np/RAbSm0mV_DjuDcEx-sPIiVILXrrkkY385kOyaa7pxYF0A#sig
http://purl.org/nanopub/x/hasPublicKey
MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB
http://purl.org/np/RAbSm0mV_DjuDcEx-sPIiVILXrrkkY385kOyaa7pxYF0A#sig
http://purl.org/nanopub/x/hasSignature
gzpouB/HsT/F/lyzDqXWhW5CLhxMdJPmxEF1OCJv9xXJyMPrF2E1c6a/olTYSsWtFlor8r57KVvu3vltR8+hvF8nALFeR1XdmRVCL2T7F4n4B/aOIWDVLD3LzXs0ZT5eW2yh3OhL+mm6AzO4maw3+8sAC20vVaKjdLVKB4ZEf8U=
http://purl.org/np/RAbSm0mV_DjuDcEx-sPIiVILXrrkkY385kOyaa7pxYF0A#sig
http://purl.org/nanopub/x/hasSignatureTarget
http://purl.org/np/RAbSm0mV_DjuDcEx-sPIiVILXrrkkY385kOyaa7pxYF0A
http://purl.org/np/RAbSm0mV_DjuDcEx-sPIiVILXrrkkY385kOyaa7pxYF0A
http://purl.org/dc/terms/created
2021-08-22T17:24:55.921+02:00
http://purl.org/np/RAbSm0mV_DjuDcEx-sPIiVILXrrkkY385kOyaa7pxYF0A
http://purl.org/dc/terms/creator
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RAbSm0mV_DjuDcEx-sPIiVILXrrkkY385kOyaa7pxYF0A
https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate
http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM
http://purl.org/np/RAbSm0mV_DjuDcEx-sPIiVILXrrkkY385kOyaa7pxYF0A
https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate
http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM
http://purl.org/np/RAbSm0mV_DjuDcEx-sPIiVILXrrkkY385kOyaa7pxYF0A
https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate
http://purl.org/np/RAhNHZw6Urw_Mccs4qy6Ws3C9CRuaHpQx8AwuApbWkqnY